Abstract
Human Papillomavirus type 16 (HPV-16) is the cause of both benign lesions and ano-genital cancers. In HPV-associated cancers the transforming properties of the expressed viral E6 and E7 proteins have been revealed by a number of different assays. We have generated transgenic mice expressing HPV-16 E6/E7 genes under the control of the murine keratin 5 gene promoter, which should confer cell-type specific expression in the basal cells of squamous stratified epithelia. Transgenic mice developed thymic hyperplasia and lung neoplasia with 100% frequency, the thymus showing a size increase at 2 months and reaching the maximum dimension at 6 months, when lung carcinomas appeared. After this time the size of hyperplastic thymi decreased, while malignant formations invaded the mediastinal area. Hepatic metastasis could be also observed in some of the animals at the autopsy and death invariably occurred around 10–11 months of age.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arbeit JM, Munger K, Howley PM, Hanahan D . 1993 Am. J. Pathol. 142: 1187–1197
Arbeit JM, Munger K, Howley PM, Hanahan D . 1994 J. Virol. 68: 4358–4368
Auewarakul P, Gissmann L, Cid-Arregui A . 1994 Mol. Cell. Biol. 14: 8250–8258
Bedell MA, Jones KH, Grossman SR, Laimins LA . 1989 J. Virol. 63: 1247–1255
Bol D, Kiguchi K, Beltran L, Rupp T, Moats S, Gimenez-Conti I, Jorcano J, DiGiovanni J . 1998 Mol. Carcinog. 21: 2–12
Boyer SN, Wazer DE, Band V . 1996 Cancer Res. 56: 4620–4624
Byrne C, Fuchs E . 1993 Mol. Cell. Biol. 13: 3176–3190
Butel JS . 2000 Carcinogenesis 21: 405–426
Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Nevins JR . 1992 Proc. Natl. Acad. Sci. USA 89: 4549–4553
Chen JJ, Reid CE, Band V, Androphy EJ . 1995 Science 269: 529–531
Chomczynski P, Sacchi N . 1987 Anal. Biochem. 162: 156–159
Clavel CE, Nawrocki B, Bosseaux B, Poitevin G, Putaud IC, Mangeonjean CC, Monteau M, Birembaut PL . 2000 Cancer 88: 1347–1352
Comerford SA, Maika SD, Laimins LA, Messing A, Elsasser H-P, Hammer RE . 1995 Oncogene 10: 587–597
Coussens LM, Hanahan D, Arbeit JM . 1996 Am. J. Pathol. 149: 1899–1917
Damak S, Harnboonsong Y, George PM, Bullock . 1996 Mol. Carcinog. 17: 84–91
Dyson N, Howley PM, Munger K, Harlow E . 1989 Science 243: 934–937
Dyson N . 1998 Genes Dev. 12: 2245–2262
Eckert RL, Crish JF, Balasubramanian S, Rorke EA . 2000 Int. J. Oncol. 16: 853–870
el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825
Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM . 1996 Cell 85: 733–744
Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA . 1997 Genes Dev. 11: 2090–2100
Gao Q, Srinivasan S, Boyer SN, Wazer DE, Band V . 1999 Mol. Cell. Biol. 19: 733–744
Gouyer V, Gazzeri S, Bolon I, Drevet C, Brambilla C, Brambilla E . 1998 Am. J. Respir. Cell. Mol. Biol. 18: 188–196
Grana X, Reddy EP . 1995 Oncogene 11: 573–582
Griep AE, Herber R, Jeon S, Lohse JK, Dubielzig RR, Lambert PF . 1993 J. Virol. 67: 1373–1384
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . 1993 Cell 75: 805–816
Heck DV, Yee CL, Howley PM, Munger K . 1992 Proc. Natl. Acad. Sci. USA 89: 4442–4446
Hennig EM, Suo Z, Karlsen F, Holm R, Thoresen S, Nesland JM . 1999 Acta. Oncol. 38: 639–647
Herber R, Liem A, Pitot H, Lambert PF . 1996 J. Virol. 70: 1873–1881
Hirayasu T, Iwamasa T, Kamada Y, Koyanagi Y, Usuda H, Genka K . 1996 J. Clin. Pathol. 49: 810–817
Hogan B, Costantini F, Lacy E . 1986 Manipulating the Mouse Embryo Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press
Howes KA, Ransom N, Papermaster DS, Lasudry JG, Albet DM, Windle JJ . 1994 Genes Dev. 8: 1300–1310
Huang MT, Gorman CM . 1990 Nucleic Acids Res. 18: 937–947
Hunter T, Pines J . 1994 Cell 79: 573–582
Jones DL, Alani RM, Munger K . 1997 Genes Dev. 11: 2101–2111
Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T, Ishibashi M . 1997 Proc. Natl. Acad. Sci. USA 94: 11612–11616
Klug DB, Carter C, Crouch E, Roop D, Conti CJ, Richie ER . 1998 Proc. Natl. Acad. Sci. USA 95: 11822–11827
Kondoh G, Murata Y, Aozasa K, Yutsudo M, Hakura A . 1991 J. Virol. 65: 3335–3339
Lambert PF, Pan H, Pitot HC, Liem A, Jackson M, Griep AE . 1993 Proc. Natl. Sci. USA 90: 5583–5587
Lechner MS, Laimins LA . 1994 J. Virol. 68: 4262–4273
Ledent C, Marcotte A, Dumont JE, Vassart G, Parmentier M . 1995 Oncogene 10: 1789–1797
Leder A, Pattengale PK, Kuo A, Stewart TA, Leder P . 1986 Cell 45: 485–495
Lee SS, Weiss RS, Javier RT . 1997 Proc. Natl. Acad. Sci. USA 94: 6670–6675
Mansur CP, Androphy EJ . 1993 Biochim. Biophys. Acta 1155: 323–345
McIntyre MC, Ruesch MN, Laimins LA . 1996 Virology 215: 73–82
Missero C, Serra C, Stenn K, Dotto GP . 1993 J. Cell. Biol. 121: 1109–1120
Moll R, Dhouailly D, Sun T-T . 1989 Virchows Archiv. B Cell. Pathol. 58: 129–145
Morozov A, Shiyanov P, Barr E, Leiden JM, Raychaudhuri P . 1997 J. Virol. 71: 3451–3457
Morris GF, Hoyle GW, Athas GB, Lei WH, Xu J, Morris CB, Friedman M . 1998 J. La State Med. Soc. 150: 179–185
Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM . 1989a EMBO J. 8: 4099–4105
Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R . 1989b J. Virol. 63: 4417–4421
Murillas R, Larcher F, Conti CJ, Santos M, Ulrich A, Jorcano JL . 1995 EMBO J. 14: 5216–5223
Nakagawa S, Watanabe S, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T . 1995 Virology 212: 535–542
Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY . 1996 Cell 85: 707–720
Nelson WG, Sun TT . 1983 J. Cell. Biol. 97: 244–251
Nikitin AY, Juarez-Perez MI, Li S, Huang L, Lee WH . 1999 Proc. Natl. Acad. Sci. USA 96: 3916–3921
Ogawa K, Imaida K, Masui T, Kawabe M, Hasegawa R, Kato K, Ito N, Shirai T . 1996 Carcinogenesis 17: 341–345
Pan H, Griep AE . 1994 Genes Dev. 8: 1285–1299
Phelps WC, Yee CL, Munger K, Howley PM . 1988 Cell 53: 539–547
Pim D, Thomas M, Javier R, Gardiol D, Banks L . 2000 Oncogene 19: 719–725
Ramirez A, Bravo A, Jorcano JL, Vidal M . 1994 Differentiation 58: 53–64
Robles AI, Larcher F, Whalin RB, Murillas R, Richie E, Gimenez-Conti IB, Jorcano JL, Conti CJ . 1996 Proc. Natl. Acad. Sci. USA 93: 7634–7638
Rodriguez-Puebla ML, LaCava M, Miliani de Marval PL, Jorcano JL, Richie ER, Conti CJ . 2000 Am. J. Pathol. 157: 1039–1050
Ronco LV, Karpova AY, Vidal M, Howley PM . 1998 Genes Dev. 12: 2061–2072
Ruesch MN, Laimins LA . 1997 J. Virol. 71: 5570–5578
Sampietro G, Tomasi G, Collini P, Biganzoli E, Boracchi P, Bidoli P, Pilotti S . 2000 Appl. Immunohistochem. Molecul. Morphol. 8: 49–56
Sandmoller A, Halter R, Suske G, Paul D, Beato M . 1995 Cell Growth Differ. 6: 97–103
Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM . 1990 Cell 63: 1129–1136
Scheffner M, Huibregtse JM, Vierstra RD, Howley PM . 1993 Cell 75: 495–505
Seavey SE, Holubar M, Saucedo LJ, Perry ME . 1999 J. Virol. 73: 7590–7598
Sedman SA, Hubbert NL, Vass WC, Lowy DR, Schiller JT . 1992 J. Virol. 66: 4201–4208
Seedorf K, Krammer G, Durst M, Suhai S, Rowekamp WG . 1985 Virology 145: 181–185
Sherr CJ, Roberts JM . 1999 Genes Dev. 13: 1501–1512
Smotkin D, Prokoph H, Wettstein FO . 1989 J. Virol. 63: 1441–1447
Song S, Pitot HC, Lambert PF . 1999 J. Virol. 73: 5887–5893
Storey A, Pim D, Murray A, Osborn K, Banks L, Crawford L . 1988 EMBO J. 7: 1815–1820
Storey A, Banks L . 1993 Oncogene 8: 914–924
Sunday ME, Haley KJ, Sikorski K, Graham SA, Emanuel RL, Zhang F, Mu Q, Shahsafaei A, Hatzis D . 1999 Oncogene 18: 4336–4347
Tong X, Howley PM . 1997 Proc. Natl. Acad. Sci. USA 94: 4412–4417
Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW, Jansen-Durr P . 1996 Oncogene 13: 2323–2330
zur Hausen H, de Villiers EM . 1994 Annu. Rev. Microbiol. 48: 427–447
zur Hausen H . 1996 Biochim. Biophys. Acta. 1288: F55–F78
zur Hausen H . 2000 J. Natl. Cancer Inst. 92: 690–698
Acknowledgements
We thank Dr GP Dotto for providing the K5Ti plasmid, Drs Cesira Galeotti and Barry Howes for careful reading of the manuscript. Alessio Benanchi for technical assistance and Giorgio Corsi for artwork.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carraresi, L., Tripodi, S., Mulder, L. et al. Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes. Oncogene 20, 8148–8153 (2001). https://doi.org/10.1038/sj.onc.1205007
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205007
Keywords
This article is cited by
-
Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins
Journal of Translational Medicine (2011)
-
Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells
Oncogene (2004)